Nevirapine-d3

• CAT Number: R048622
• CAS Number: 1051419-24-9
• Molecular Formula: C15H14N4O
• Molecular Weight: 269.32
• Purity: ≥95%
• Synonyms: 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2’,3’-e][1,4]diazepin-6-one-d3; BI-RG 587-d3; NSC 641530-d3; Nevarapine-d3; Viramune-d3
• Storage: -20°C
• IUPAC Name: 2-cyclopropyl-7-(trideuteriomethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
• InChI: InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)/i1D3
• InChIKey: NQDJXKOVJZTUJA-FIBGUPNXSA-N
• SMILES: [2H]C([2H])([2H])C1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4

Nevirapine-d3（Cat No.:R048622） is a high-purity deuterated compound featuring three deuterium atoms, essential for advanced pharmaceutical and biomedical research. This isotopically labeled version of nevirapine is crucial for studies involving antiretroviral drug metabolism, pharmacokinetics, and pharmacodynamics. Its stable isotope labeling ensures precise and reliable analytical results, enhancing the accuracy of experimental data. Ideal for use in bioavailability studies, drug interaction investigations, and analytical method development, Nevirapine-d3 integrates seamlessly into existing research protocols, offering a robust and cost-effective solution for high-precision scientific investigations in HIV therapy and therapeutic monitoring.